A Danish pharmaceutical company wanted a new approach to increase adherence during treatment. Therefore, they asked us to perform a behavioural audit of their existing marketing material for one of their drugs.
We took the company’s existing and comprehensive data as the basis for the analysis, but we interpreted the provided material and insights through the lens of behavioural science. The material addressed a medical problem that is characterised by substantial normative and social factors.
Our recommendation for a new strategy was to accommodate the barriers that related to identity and decrease the referrals to clinical arguments, both in the marketing material and in the physician’s prescription.
Additionally, we made an intuitive visualisation of the effect of the drug, which gave the patients the required motivation to adhere to the treatment even when symptoms were lacking.
Anonymous Pharma Company: